Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras homolog family member T1 pseudogene 3 (RHOT1P3) is a segment of DNA sharing sequence similarity with the protein-coding RHOT1 gene but is unable to encode a functional protein due to disabling mutations or lack of regulatory elements[3]. Pseudogenes like RHOT1P3 may be transcribed as RNA and can have regulatory effects on related coding genes by serving as competing endogenous RNAs (ceRNAs), acting as decoys for microRNAs, or generating small interfering RNAs involved in post-transcriptional gene regulation[1]. However, pseudogenes are generally not considered molecular targets for therapy, and there is currently no evidence that RHOT1P3 is involved in any established disease process or is targeted by any drug. Many pseudogenes are annotated but not functionally characterized, and RHOT1P3 is among those pseudogenes without characterized biological or clinical importance[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras homolog family member T1 pseudogene 3 (RHOT1P3).